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Objectives: To define the status of Infectious Diseases (ID) as an approved specialty in Europe; to 
enumerate the number of specialists (in general and in relation to the overall population) and 
specialist trainees and describe the content, delivery, and evaluation of postgraduate training in ID in 
different countries. 
Methods: Structured web-based questionnaire surveys in March 2021 of responsible national 
authorities, specialist societies and individual country representatives to the Section of Infectious 
Diseases of the European Union for Medical Specialties. Descriptive analysis of quantitative and 
qualitative responses. 
Results: In responses received from 33/35 (94.3%) countries, ID is recognised as a specialty in 24 and 
as a subspecialty of general internal medicine (GIM) in 8, but it is not recognised in Spain. The 
number of ID specialists per country varies from <5 per million inhabitants to 78 per million. Median 
length of training is 5 (IQR 4.0 - 6.0) years with variable amounts of preceding and/or concurrent 
GIM. Only 21.2% of countries (7/33) provide the minimum recommended training of 6 months in 
microbiology and 30% cover competencies such as palliative care, team working and leadership, 
audit, and quality control. Training is monitored by personal logbook or e-portfolio in 75% (25/33) 
and assessed by final exams in 69.7% (23/33) of countries, but yearly reviews with trainees only 
occur in 54.5% (18/33) of countries. 
Conclusions: There are substantial gaps in modernisation of ID training in many countries to match 
current European Training Requirements. Joint training with clinical microbiology and in 
multidisciplinary team working should be extended. Training/monitoring trainers should find greater 









The current COVID-19 pandemic has reinforced the need for Infectious Disease (ID) specialists and 
Clinical Microbiologists (CM) to collaborate across Europe, meeting the threats of emerging 
infections and, future pandemics [1, 2]. Recognition and management of infections acquired during 
travel or migration is increasingly important [2-4], as are countering antimicrobial resistance, with 
proven effectiveness of antimicrobial stewardship and specialist advice on patient management [4, 
5] and of infection prevention and control [6, 7]. There is a wide range of provision of clinical 
specialists in infection in different countries, with significant overlap of many areas of professional 
practice [8]. The need for additional staffing, collaborative clinical work, training, and research 
between ID and CM has been repeatedly emphasized over the past 20 years [8-11]. 
In 2018, the Section for Infectious Diseases of the European Union of Medical Specialists (UEMS-ID) 
published an updated European Training Requirement (ETR) recommending indicative training 
periods of a minimum of 2 years in General Internal Medicine (GIM) and 4 years of specialty ID 
training [12]. The development of the ETR and its predecessors has been summarised elsewhere [10, 
13]. In addition to curricula with details of professional competencies to be achieved by the trainee 
and methods of assessing trainees’ progress, there is strong emphasis on adequate organisation of 
training, accreditation of specialists as trainers, and approval and monitoring of training programmes 
[13]. 
This article describes the status of ID training across Europe in 2021 including clinical assessment, 
curricular updates, and governmental regulation. It examines early effects of the COVID-19 
pandemic on training and possible future impacts. Areas for future improvement are outlined, for 
countries to learn and adopt good practice from one another. 
Methods 
Information was collected from practitioners throughout Europe in March 2021 utilising electronic 







authorities and/or ID specialist societies of the 35 full or associate UEMS member states. 
Respondents were then contacted electronically and by telephone up to five times for follow-up 
queries and validation of data (Figure 2). The electronic case report forms (eCRF) were based on 
previous data collection at annual meetings of the UEMS-ID section, revised and then developed 
with the EFS Survey™ (Questback, Cologne, Germany). For further detail see Appendix A. 
Results 
Statistical overview and recent development in terms of ID accreditation 
Full responses were received from 33/35 (94.3%) countries (Table 1). ID is regarded as a specialty in 
24 countries, as a subspecialty of GIM in 8 and is not recognised in one (Fig 1). ID was approved as an 
independent specialty in France in 2011 and in Germany in 2021, and as a subspecialty of GIM in 
Belgium in 2020. Official approval in Spain has been awaited for over a decade, despite training 
being well established in several university centres. Paediatric ID is recognised as a separate 
specialty or subspecialty of paediatric medicine in at least 17/33 (51.5%) countries. 
The population adjusted number of adult ID specialists varies from <5 per million inhabitants in 
Austria, Ireland, and the UK to >40 per million in Iceland, Latvia, and Lithuania, with 78 per million in 
Sweden (Table 1). Numbers tend to be higher in countries where ID is an independent specialty. 
There was similar wide variation in the number of trainees. Central workforce planning, i.e., 
matching trainee numbers to the anticipated need for future specialists, was recorded in 13/24 
(54.2%) countries where ID is a specialty compared to 1/8 (12.5%) where it is a subspecialty. 
ID Specialist training – numbers, institutions, overall structure and areas of training 
Specialist training is delivered in all countries except Luxembourg and Iceland. The ratio of trainers 
to the total number of specialists varies from <5% (30:800) in Sweden to almost 100% in Austria, 
Denmark, Ireland, Israel and Malta and there was similar variation in the number of available 
training centres. In some countries access to training centres was limited due to insufficient numbers 








and control of centres and trainees varies between countries and trainee salaries may not be 
centrally funded. Trainees receive some sort of salary everywhere but access to fully funded training 
rotations may be limited. For example, in Armenia, trainees must pay tuition fees if they are not 
accepted on a state allocated residency. 
Combinations of training patterns and their indicative length vary across Europe (Table 1). In 
countries where ID is a separate specialty, specialist training takes a median 5 (IQR 5 – 6) [range 1 – 
7] years, with a median of 1.8 (IQR 1 – 3) [range 0.3 – 5] years initial “common trunk” GIM training 
followed by ID training. However, some countries require concurrent or sequential accreditation in 
GIM for appointment as a specialist. Similar requirements are being introduced in 2021 in Ireland 
and in the UK for trainees who are not undergoing joint training in ID and Medical Microbiology 
(MM) or Virology. In Estonia, the content of GIM training is being increased in 2022. Only three 
countries (Estonia, Turkey and the UK) provide concurrent specialist training in ID and MM/Virology. 
This is being introduced in 2021 in Ireland and revised in the UK, where ID training will be combined 
for seven years total with either GIM (3 years common trunk GIM training) or with MM/Virology (2 
years common trunk GIM training) [13, 16]. In countries where ID is a subspecialty or not officially 
recognised, trainees usually complete 2.3 to 5 years of GIM training (median 4) (IQR 3.3 – 4.5) before 
entering a median 2.5 (IQR 2 – 5) years of ID specialty training [range 2 – 6]. 
Overall, 54.5% of countries (18/33) provide training across all 3 main activity headings - direct 
inpatient care, consults and outpatient clinics (Table 2). Time allocation to these areas varies widely 
and may overlap throughout all training (the majority) or be performed in rotation. In Israel, there 
are no specific ID wards, and emphasis is on consult activity and infection prevention and control 
activity. There is greater focus on training and provision of dedicated inpatient care in southeast 
Europe. Although 29/33 (87.9%) countries include a training attachment in an MM laboratory, the 
duration varies from 1-12 months and only 7/33 (21.2%) allocate ≥6 months of training as 








ID specialist training – curricular contents 
The main “traditional” components of the ETR curriculum are delivered in most countries, with 
varying degrees of emphasis (Table 2). In Armenia, the Czech Republic, Hungary and Lithuania, care 
of non-HIV immune-compromised patients and sexually transmitted infections are excluded. Some 
respondents mentioned the need for more extensive and practical training in microbiology. The 
questions on tropical and travel medicine were not answered consistently but these areas were 
included in 31/33 (93.9%) countries. It was unclear how many countries provide specific training and 
accreditation in “Tropical Medicine” similar to that provided in the UK [13, 16, 17]. 
Newer aspects of the training curriculum are only delivered in 30% of countries, with training in 
palliative care in 11, quality improvement/audit in 13 and leadership/team management in 12. 
However, a new curriculum was approved in Slovenia in 2021, meeting the ETR criteria and 
foreseeing additional training in bedside ultrasound. Apart from Croatia, the Czech Republic and 
Slovakia, research methodology is part of the curriculum and encouraged in all countries and in 
39.4% of countries, trainees may take time out of clinical training to focus on research. The revised 
Finnish curriculum foresees a 6-months funded rotation into clinical research, whereas French 
trainees defend a thesis before the end of the penultimate year. 
Measures of training assessment for trainees, trainers and institutions 
Trainee progress is monitored by personal logbook or e-portfolio in 25 countries (75.8%). Workplace 
based assessments are used in 17 (51.1%) and knowledge-based assessments in 20 (60.6%) (Table 
2). In some countries, regular assessments are formative and may be trainee-led, whereas in 
Portugal trainees must pass activity reviews and yearly exams. Regular formal reviews of training are 
conducted in at least 18 countries (54.5%), with a penultimate year assessment in 4. At least 69.7% 
of countries require final examinations, usually written, with additional oral and/or clinical bedside 








Approval of centres and trainees is performed by bodies such as Ministries of Health, national 
medical bodies or colleges, specialist societies or individual universities. Supervisors are usually 
required to have been an accredited specialist for at least three to five years, and training centre 
approval requires presence of sufficient clinical activity and/or ID bed base, and enough specialists 
(typically ≥2). Renewal of approval of centres, typically in a 5-year cycle, is required in some 
countries. Some respondents suggested the need for more structured and frequent quality control 
of mentors/trainers. 
Influence of COVID-19 Pandemic 
There has been an increase in ID trainees in six countries and further increase is expected in 13. Due 
to the ongoing COVID-19 pandemic, the Lithuanian government increased funding of ID residency 
positions. The University of Tartu (Estonia) is applying for additional residency positions and 
considers increasing epidemiology studies within the curriculum. Some respondents thought that 
the pandemic will improve the external perception of ID as a specialty, while others were concerned 
about loss of trainees due to physician exhaustion and “burn out”. 
Discussion 
This paper provides important insights into the status of ID training programmes across Europe, 
relying primarily on reports and opinions from senior physicians in each country. Previous reviews 
have shown variations in format and duration of training, supervision and examinations between 
countries, and 20% of countries lacked formal training programmes in 2005[9-11]. The situation has 
now improved with only 1 country in 35 awaiting specialty recognition, but there is still substantial 
variability in the numbers of ID specialists per million inhabitants and in the central regulation of the 
number of future specialists in training. As highlighted previously [9-11], a recent internet-based 
survey of ESCMID members and affiliates found that only 58% of hospitals had a specialised ID ward 
and that there was an average of 1 ID or CM physician per 100 hospital beds [8]. Although practice 







outpatient and consult practice to become a specialist. Any further subspecialisation occurs 
informally or formally after specialist accreditation [18]. 
Investigation of the number of specialist trainees in each country proved difficult, emphasising the 
need for central national databases to track numbers of trainees and their progress. However, in 
some countries the approval of training centres, funding of training and control of training content 
and delivery are functions of different ministries/national authorities. 
The length of training varies from one to seven years. There is an increasing trend towards double 
training in ID and GIM, in keeping with the general trend seen in UEMS across all specialties allied to 
GIM. Very few countries provide dual training in ID with MM or Virology and such programmes tend 
to have shorter GIM components. Only 21.2% of countries provide the minimum 6 months of 
microbiology training recommended in the ETR [12], which seems disappointing given the emphasis 
on the need for improved training in antimicrobial stewardship, infection control and joint ID/MM 
training recommended more than 15 years ago [9]. Familiarity with laboratory practice improves 
interpretation of results and reports and also underpins better antimicrobial stewardship. Detailed 
surveys of training needs have led to the introduction of new European standards of practice and 
training programmes in antimicrobial stewardship and infection prevention and control [8, 19-21]. 
These could be incorporated more explicitly in the next iteration of the ETRs of both ID and CM as a 
benchmark of modernising training programme content [13]. New areas of the ID curriculum such as 
palliative care, team leadership and quality improvement have yet to be implemented in many 
countries. However, these are important because of the increasing emphasis on multidisciplinary 
team working as part of everyday ID practice. 
In all countries that responded, trainees were paid some form of salary during specialist training, 
although previous studies have found great variability of yearly gross salary across Europe [22]. This 
will have a financial impact on clinicians and may deter some from training in those countries, and 







A standardised training programme detailing each rotation should be given to trainees prior to 
commencing training, which should be provided from accredited training centres with independent 
reviews of educational supervisors. This should ensure that time is allowed for adequate experience 
in each area and that training meets the desired European standard. However, free text comments 
revealed confusion about accreditation of specialists as trainers on the basis of clinical seniority, 
rather than specific training in supervision and mentoring of postgraduate trainees. It is a great 
concern that only half of countries conduct annual reviews of trainee progress and that even less 
conduct a more global review to identify unmet training needs just before the last year of training. 
These shortcomings echo the findings of previous ESCMID surveys, in which only 34% of trainees 
received regular constructive feedback from their supervisor and there were notable differences in 
supervision of trainees in different European regions [23]. Only 36% of ID/CM European trainees 
were assigned an official mentor during their training and of these, only 60% received constructive 
feedback on their work [24]. More than a quarter did not consider their relationships with mentors 
to be confidential and 22% felt they could not talk with their mentor if treated unfairly at work [24]. 
Trainee feedback is an important factor in developing and improving curricula and training 
programmes [21, 23]. Our findings support the need for improvement in postgraduate education in 
ID in many European countries. Further innovative approaches to delivering such training could also 
be considered [25]. 
 Research opportunities vary among countries depending on priorities and prior experience. Extra 
time is needed, often out of training, and funding may or not be available from training fellowships, 
charities or governmental organisations. Protected time spent in a research rotation allows trainees 
to further define their skills in terms of international comparison and finding new niches within their 
chosen specialty. 
This study was limited due to the personal response of each clinician completing the questionnaire 
on behalf of their country and slight ambiguity of interpretation of a few questions. Efforts have 









The COVID-19 pandemic has gathered international attention to ID as a specialty and was cited by 
several countries as a stimulus to train more ID specialists. It has highlighted the need for more ID 
specialists across Europe and the importance of unity and collaboration amongst countries and 
between the infection specialties in managing such. The specialty should strive to improve training in 
areas such as antimicrobial stewardship and infection prevention and control. In many countries, 
improvement and modernisation of the framework for delivery of postgraduate training is needed to 
enhance the training experience and maintain enthusiasm among our excellent trainees. Ideally, ID 
trainees will benefit from a harmonised curriculum offering equivalent standards of training and 
professional opportunity across the continent with equitable working conditions encouraging free 
movement of specialists between European countries. 
Author contributions 
Dušek D developed the first draft of the survey 1 and 2. Subsequent drafts were further developed 
and finalised by Brockhoff RA, Salmanton-García J, Beeching NJ and Cornely OA. Brockhoff RA, Hicks 
RS, Salmanton-García J, Stahl JP, Beeching NJ and Cornely OA collected data, and analysed and 
interpreted the findings. All authors contributed to all sections relevant to their experience and 
helped finalise the text and content. Brockhoff RA and Hicks SR, as first authors, so as Beeching NJ 
and Cornely OA as senior authors, contributed equally to this manuscript. 
Declaration of interest 
OAC reports grants and personal fees from Actelion, Amplyx, Astellas, Basilea, Cidara, Da Volterra, 
F2G, Gilead, MedPace, Merck/MSD, Pfizer, Scynexis; grants from DFG (German Research 
Foundation), German Federal Ministry of Research and Education, Immunic, Janssen, Medicines 
Company, Melinta Therapeutics; personal fees from Allecra Therapeutics, Al-Jazeera 








Menarini, Molecular Partners, MSG-ERC, Mylan, Nabriva, Noxxon, Octapharma, Paratek, PSI, Roche 
Diagnostics, Seres, Shionogi; others from Wiley (Blackwell); outside the submitted work. 
Funding 
No external funding was received. 
Acknowledgments 
This article is dedicated to the memory of our colleague Davorka Dušek who contributed so much to 
her patients and to the professional infection community across Europe, but sadly passed away 
during the development of the survey. We thank all those who contributed their time and expertise 
in responding to the questionnaires, and colleagues across the UEMS Section and Board of ID for 









[1] Koehler P, Bassetti M, Chakrabarti A, Chen SCA, Colombo AL, Hoenigl M, et al. Defining and managing COVID-19-
associated pulmonary aspergillosis: the 2020 ECMM/ISHAM consensus criteria for research and clinical guidance. 
Lancet Infect Dis 2021;21(6):e149-62. 
[2] Petersen E, Petrosillo N, Koopmans M, ESCMID Emerging Infections Task Force Panel. Emerging infections-an 
increasingly important topic: review by the Emerging Infections Task Force. Clin Microbiol Infect 2018;24(4):369-75. 
[3] Schlagenhauf P, Weld L, Goorhuis A, Gautret P, Weber R, von Sonneburg F, et al; EuroTravNet.  Travel-associated 
infection presenting in Europe (2008–12): An analysis of EuroTravNet longitudinal, surveillance data, and evaluation 
of the effect of the pre-travel consultation. Lancet Infect Dis 2015;15:55–64. 
[4] Bloom DE, Cadarette D. Infectious disease threats in the twenty-first century: strengthening the global response. 
Front Immunol 2019;10:549. https://doi.org/10.3389/fimmu.2019.00549 
[5] Schmitt S, McQuillen DP, Nahass R, Martinelli L, Rubin M, Schwebke K, et al. Infectious diseases specialty 
intervention is associated with decreased mortality and lower healthcare costs. Clin Infect Dis 2014;58(1):22-8. 
[6] Tsioutis C, Birgand G, Bathoorn E, Deptula A, Ten Horn L, Castro-Sánchez E, et al. Education and training 
programmes for infection prevention and control professionals: mapping the current opportunities and local needs 
in European countries. Antimicrob Resist Infect Control 2020;9(1):183. 
[7] Brouqui P, Puro V, Fusco FM, Bannister B, Schilling S, Follin P, et al. Infection control in the management of highly 
pathogenic infectious diseases: consensus of the European Network of Infectious Disease. Lancet Infect Dis 
2009;9(5):301-11. 
[8] Dickstein Y, Nir-Paz R, Pulcini C, Cookson B, Beovic B, Tacconelli E, et al. Staffing for infectious diseases, clinical 
microbiology and infection control in hospitals in 2015: results of an ESCMID member survey. Clin Microbiol Infect 
2016;22(9):812 e9- e17. 
[9] Cooke FJ, Choubina P, Holmes AH. Postgraduate training in infectious diseases: investigating the current status in 
the international community. Lancet Infect Dis 2005;5(7):440-9. 
[10] McKendrick MW, European Union of Medical Specialties. The European Union of Medical Specialties core 
training curriculum in infectious diseases: overview of national systems and distribution of specialists. Clin Microbiol 








[11] Read RC, Cornaglia G, Kahlmeter G; European Society of Clinical Microbiology and Infectious Diseases 
Professional Affairs Workshop Group. Professional challenges and opportunities in clinical microbiology and 
infectious diseases in Europe. Lancet Infect Dis 2011;11(5):408-15. 
[12] European Union of Medical Specialists (UEMS). Training Requirements for the Specialty of Infectious Diseases - 
European Standards of Postgraduate Medical Specialist Training, 2018  [Available from: 
https://www.uems.eu/__data/assets/pdf_file/0004/72265/ETR-in-Infectious-Diseases-2018-corrected-1.pdf 
[accessed 28 June 2021] 
[13] Beeching NJ, Rautelin H, Stahl J-P, Leegard TM. Training and assessment of medical specialists in clinical 
microbiology and infectious diseases in Europe. Clin Microbiol Infect 2021. 
[14] The World Data Bank. Popular indicators, 2019  [Available from: 
https://databank.worldbank.org/indicator/SP.POP.TOTL/1ff4a498/Popular-Indicators [accessed 28 June 2021] 
[15] Deutsche Gesellschaft für Infektiologie. Weiterbildungsstellen "Infektiologie" Deutschland, 2020  [updated 
27.10.2020. Available from: https://www.dgi-net.de/wp-content/uploads/2020/10/Weiterbildungsstellen-
Deutschland-2020-10-27-1.pdf [accessed 28 June 2021] 
[16] Joint Royal Colleges of Physicians Training Board. Infectious Diseases and Tropical Medicine, 2021.  [Available 
from: https://www.jrcptb.org.uk/specialties/infectious-diseases-and-tropical-medicine [accessed 28 June 2021] 
[17] Beeching NJ, Borysiewicz LK. Training in infectious diseases and tropical medicine in Britain. Clin Microbiol Infect 
2000;6(8):432-4. 
[18] Bonura EM, Armstrong WS. Increasing subspecialization in the field of infectious diseases: evaluating challenges 
and strategies to move forward. J Infect Dis 2017;216(suppl_5):S594-S9. 
[19] Zingg W, Mutters NT, Harbarth S, Friedrich AW. Education in infection control: A need for European 
certification. Clin Microbiol Infect 2015;21(12):1052-6. 
[20] Maraolo AE, Ong DSY, Cimen C, Howard P, Kofteridis DP, Schouten J, et al. Organization and training at national 
level of antimicrobial stewardship and infection control activities in Europe: an ESCMID cross-sectional survey. Eur J 







[21] Yusuf E, Ong DS, Martin-Quiros A, Skevaki C, Cortez J, Dedic K, et al. A large survey among European trainees in 
clinical microbiology and infectious disease on training systems and training adequacy: identifying the gaps and 
suggesting improvements. Eur J Clin Microbiol Infect Dis 2017;36(2):233-42. 
[22] Tacconelli E, Poljak M, Cacace M, Caiati G, Benzonana N, Nagy E, et al. Science without meritocracy. 
Discrimination among European specialists in infectious diseases and clinical microbiology: a questionnaire survey. 
BMJ Open 2012;2(6):e001993. 
[23] Palacios-Baena ZR, Zapf TC, Ong DSY, Maraolo AE, Ronnberg C, Cimen C, et al. How are trainees in clinical 
microbiology and infectious diseases supervised in Europe? An international cross-sectional questionnaire survey by 
the Trainee Association of ESCMID. Eur J Clin Microbiol 2018;37(12):2381-7. 
[24] Ong DSY, Zapf TC, Cevik M, Palacios-Baena ZR, Barac A, Cimen C, et al. Current mentorship practices in the 
training of the next generation of clinical microbiology and infectious disease specialists: an international cross-
sectional survey. Eur J Clin Microbiol 2019;38(4):659-65. 
[25] Cervantes J. The future of infectious diseases education. Med Sci Educ 2020;30:1783–5. 
[26] Bundesärztekammer. Ärztinnen/Ärzte mit Zusatz-Weiterbildungen nach Tätigkeitsarten, 2019  [updated 
31.12.2019. Available from: https://www.bundesaerztekammer.de/fileadmin/user_upload/downloads/pdf-
Ordner/Statistik2019/Stat19Tab11.pdf [accessed 28 June 2021] 
[27] Bundesärztekammer. Liste der Landesärztekammern, 2021  [updated 09.01.2018. Available from: 
https://www.bundesaerztekammer.de/service/adressen/landesaerztekammern/ [accessed 28 June 2021] 
[28] Bundesärztekammer (Arbeitsgemeinschaft der deutschen Ärztekammern). (Muster-) Weiterbildungsordnung, 
2018  [updated 13.11.2020. Available from: 
https://www.bundesaerztekammer.de/fileadmin/user_upload/downloads/pdf-







Table 1: Status of Infectious Disease training and service provision in 33 European countries (full or associate members of UEMS). 















Paediatric ID Formal 
exam 
Countries in which 



























Armenia 55 18 10 15 2 - Yes 3 - Subspecialty o, w 
Croatia 130 32 30 10 4 - Yes 5 2 CT* Specialty C 
Czech Republic 350 33 10 45 27 - Yes 5 3 CT - c, o 
Denmark
 
140 24 9 110 5 Yes Yes 5 1.75 CT - - 
Estonia 40 31 3 10 6 Yes Yes 4 0.5 CT Subspecialty o, w 
Finland 50 9 5 5 5 - - 6 3 CT* Subspecialty w 










 [27][31] - Yes [28][32] 1 [28][32] 5* [28][32] - o [28][32] 








Ireland 19 4 6 18 7 Yes Yes 7 
3 CT* + 2 
or 
2 CT* only 
- - 
Italy 1500 25 97 100 25 Yes Yes 4 0.3 CT - o, w 
Latvia 100 53 UNK UNK 2 Yes Yes 5 UNK* Specialty c, o, w 




2 Yes Yes 4 2 CT* Subspecialty c, o, w 
Luxembourg
b 
6 10 1 1 1 No No - - - - 
Malta
c 
7 14 1 8 1 Yes Yes 6 2* + 3 CT Subspecialty w 
Poland 1131 30 130 45 76 - Yes 5 0.7 CT - o, w 
Portugal 300 29 18 90 12 Yes Yes 5 1 CT - c, o 
Romania 700 36 50 300 6 Yes Yes 5 2 CT - c, o, w 
Slovakia 80 15 5 - 3 No Yes 5 1 CT* - o, w 
Slovenia 105 50 40 24 5 Yes Yes 6 1.1 CT Specialty c, o 
Sweden 800 78 200 30 30 - Yes 5 1 CT - - 
Switzerland 300 35 15 40 5 - Yes 6 3 CT* Subspecialty c, o, w 








United Kingdom 273 4 70 200 40 Yes Yes 7 
3 CT* + 2 
or 
2 CT* only 
Subspecialty w 
Countries in which 
ID is a subspecialty  
           
Austria 7 1 2 7 42
k 
- Yes 6 2.25 CT - o, w 
Belgium
d 
100 9 20 40 10 - Yes 4 3.5* - - 
Cyprus
e 
10 8 - - - - Yes 2 5* Subspecialty o, w 
Greece 70 7 10 20 6 - Yes 2 5* Subspecialty o, w 
Iceland
f
 20 50 - - - - - 3 3 CT* Subspecialty - 
Israel 235 26 12 235 18 - Yes 2 4 CT* Subspecialty o, w 
Netherlands 150 9 20 10 7 - Yes 2 4* Specialty - 
Norway 175 33 14 100 4 Yes Yes 6 4 CT - - 
Countries in which 
ID is not a specialty 
           
Spain
g
 400 9 50 UNK 30 - No UNK - - - 









c, clinical exam; CT, Common Trunk; GIM, General Internal Medicine; ID, Infectious Diseases; n, number; o, oral exam; UNK, unknown; w, written exam; -, not applicable 
*Training in GIM precedes ID training; 
a
In May 2021, ID was recognised as a specialty in Germany. The implementation of an official training curriculum with regards to the Decree is anticipated. 
b
In Luxembourg, ID specialists are trained 
abroad (predominantly in Belgium; also, France and Spain). Trainees spend one year of training in Luxembourg. After that, training is continued abroad. 
c
In Malta, ID is considered a specialty in terms of training, but as a subspecialty 
within the working system of the Department of Medicine.  Employment requires specialisation in both, GIM and ID. 
d
Numbers for Belgium are based on estimates. ID was recognised as subspecialty for the first time in May 2020. 
e
In 
Cyprus, there are no official training centres. Based on a Bilateral Agreement between Cyprus and Greece. Cypriote, Greek and EU citizens can perform their ID residency in Cypriote hospitals, if accredited by the Greek Ministry of Health. 
f
In Iceland, there are no training institutions. ID training is performed abroad (Sweden, UK, USA). 
g
ID is not recognised as a specialty in Spain. Training delivery and duration are highly variable depending on local regulations and training 
institutions. Trainees participate in different courses/rotations. 
h
Current numbers are estimates supported by statistics of the previous year. 
i
Only 31 of 124 training centres are accredited by the German Society for Infectious Diseases 
and therefore comparable to European standards. 
j
In Lithuania, a decrease in numbers of trainees terminating ID Training has been observed due to structural problems caused by the COVID-19 pandemic. 
k
 In Austria, there are a total of 








Table 2: Infectious Diseases training delivery in 33 European countries in 2021 in comparison to the UEMS European Training Requirements for the 























































































































































































































































































































































































































































































Armenia 1* 24 5 1 - - X X - X X X X 
 
X X X X - - - - - - - X E 
Austria 3* - - - X - - - - X - - X X X X X X X - - X - - X X X 
Belgium
1 
6 18 6 18 X X X X - X X - X X - X - X - - 6 X - - X X E 
Croatia 5 - - - X X X - - X X X X X X X X X X - 3 X - - X X - 
Czech Republic 1 X - X X X X - - - X X X X - X X X - - X - - - - X - 
Cyprus
2 
1 X X X - - - - - X X X X X X X X X X - 1 X - X X X e 






























































































































































































































































































































































































































































































Estonia 3 40 12 6 X X - - - X X X X X - X - X 6 - 3 X X X - X e 
Finland 3* 9 9 9 - - - - - - - - X X 6 X X X X - 6 X X - - X 6, e 
France 6 48 - 6 X - - X X - - - X X X X X X X - 6 X X - X X e 
Germany [28] - 12 12 - X - - X - X X - X X X X X X X - - X - - X X E 
Greece 1 14 3 14 X - - - - X X X X X X X X X 3 - X X - X X X e 
Hungary 3 42 - - X - - - - X X X - - X - X - 2 - 3 - - - - - e 
Iceland
3
 - - - - - X X - - - - - X X X X X X X X - X - X X X E 
Ireland
4 
1 36 36 36 X X X X X X X X X X X X X X X X X X - X X X E 
Israel 1 - 18 - - - - - - - - - X 3* - X X X 3* - X X - - X 3* 3*, e 






























































































































































































































































































































































































































































































Latvia 6 X - - X - X - - X X X X X X X X X X - - X X - X X e 
Lithuania 1 12 6 3 - - X X - X X X X X X X X X X - 2 X X - - X e 
Luxembourg
5
 - - - - - - X X - X - - X X - X - - - - - - - - x x e 
Malta 1* 48 48 48 X - - X - - - X X X X X X X X X - X X X X X e 
Netherlands 1 6 6 9 X X X X - X X X X X X X X X X - X X - - X X E 
Norway 12 60 60 60 X X - X X X - X X X X X - X X - 12 X - - X X X 
Poland 1 48 24 - X X X X - - - X X 2 X X 1 X X X - X - - X X e 
Portugal 3 30 3 3 - X X X - - X - X X - X X X X X 3 X - - X X e 
Romania 3 24 30 - X - X X - - - - X X X X X X 3 X 3 X X X X X e 






























































































































































































































































































































































































































































































Slovenia 5 45 12 3 X X X X - X X X X X X X X X 3 X 5 X X X X X E 
Spain
6
 - - - - X X - - - X - - X X X X X X X X - X - X X X E 
Sweden 6 18 12 4 X X X X - - X X X X X X X X X X 6 X X X - X E 
Switzerland 3* - 18 12 X X X X - - X X X X X X X X 6* X 6* X - X X X E 
Turkey
4 
6* 24 20 4 X X X - - - X - X X X X - X X - 6 X - - X X e 
United Kingdom
4 
6 18 30 30 X X X X X X X X X X X X X X X X 6 X X X X X E 
No responses were received from Bulgaria or Serbia. All numbers are indicative or mandatory duration in month(s) (which may be concurrent/overlap). ABS, Antibiotic Stewardship; CAI, community acquired infections; E, encouraged 
WITH possibility to take time off; e, encouraged WITHOUT possibility to take time off; HAI, healthcare acquired infections; IC, immunocompromised; Lab, laboratory; unk, unknown; -, not applicable; x, applicable. 
*Optional, duration in month(s) 
1
Infectious Diseases was recognized as a subspecialty in May 2020. The curricular specifications are the ones listed in law, still to be implemented practically by Recognition Committees. 
2
In Cyprus, there 
are no official training centres. Based on a bilateral Agreement between Cyprus and Greece. Cypriote, Greek and EU citizens can perform their ID residency in Cypriote hospitals, if accredited by the Greek Ministry of Health. 
3
ID training 
is performed abroad (i.e., Sweden, United Kingdom, United States). 
4 
In Ireland, Turkey and the UK there will be additional laboratory-based training for those undertaking joint training with medical microbiology. 
5
In Luxembourg, ID 
specialists are trained abroad (predominantly in Belgium; also, France and Spain). Trainees spend one year of training in Luxembourg. After that, training is continued abroad. 
6
ID is not recognised as a specialty in Spain. Training 










Details of research methodology 
In a first questionnaire sent to UEMS-ID practitioners (Supplementary table 1), national authorities, 
responsible for statistical supervision, curricular content and delivery of ID training, were identified. 
In a second questionnaire (Supplementary table 2), both UEMS-ID and national authority 
representatives were asked to provide details on ID training for their respective country, including 
numbers of active ID specialists, trainees, trainers and training institutions. Details were also 
requested on training structure and curriculum contents, together with comments on measures of 
training assessment, quality assurance and research encouragement. The selection of questions 
aimed to harmonize with the UEMS European Training Requirements [12]. Information was expected 
from one responsible UEMS-ID physician per country. If more than one result was obtained and data 
showed variation, respondents for that country were asked to agree on the most probable and 
adequate information. Some representatives mentioned cooperation with their respective national 
authorities for data acquisition and validation. In countries without UEMS representation or 
response, specialist societies were contacted for data. 
All respondents were encouraged to elaborate their opinions on aspects of training in free text. 
Information collated from the survey was tabulated (Tables 1 and 2, Fig. 1). Any incomplete or 
unclear information was clarified via personal contact with the respective respondents. Websites of 
National Health Institutes served as an online source for any incomplete data, validation of such and 
contact information on eligible respondents. All data were analysed via Microsoft Excel. Data on the 
population of each country were retrieved from the world data bank website [14] and then used to 
determine the ratio of active ID specialists per million inhabitants for each individual country (total 
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ID, infectious diseases; NA, national authority;
UEMS, [Union Européenne des Médecins Spécialistes] European Union of Medical Specialists
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